These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6784230)

  • 1. The values of synthetic substrates in the improvement of diagnostic tests for haemostatic function.
    Seghatchian J
    Ric Clin Lab; 1981; 11(1):11-25. PubMed ID: 6784230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The determination of inhibitors of haemostasis using chromogenic substances (author's transl)].
    Jürgens H; von Voss H; Göbel U
    Klin Padiatr; 1980 Jul; 192(4):330-5. PubMed ID: 7192767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Clin Chem; 1983 Feb; 29(2):225-36. PubMed ID: 6821923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.
    Bassus S; Wegert W; Krause M; Escuriola-Ettinghausen C; Siegemund A; Petros S; Scholz T; Scharrer I; Kreuz W; Engelmann L; Kirchmaier CM
    Platelets; 2006 Sep; 17(6):378-84. PubMed ID: 16973498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates.
    Jha NK; Shestopal SA; Gourley MJ; Woodle SA; Liang Y; Sarafanov AG; Weinstein M; Ovanesov MV
    Haemophilia; 2016 Sep; 22(5):780-9. PubMed ID: 27038076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic substrate assays of the coagulation enzymes and their inhibitors. Comparison with clotting and immunologic methods for clinical and experimental usage.
    Messmore HL; Fareed J; Kniffin J; Squillaci G; Walenga J
    Ann N Y Acad Sci; 1981; 370():785-97. PubMed ID: 7023331
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New possibilities for quantitative determination of blood clotting and fibrinolytic factors].
    Ivanov V; Shipkov T
    Vutr Boles; 1982; 21(6):7-13. PubMed ID: 6761966
    [No Abstract]   [Full Text] [Related]  

  • 13. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test systems with synthetic peptide substrates in haemostaseology.
    Witt I
    Eur J Clin Chem Clin Biochem; 1991 Jun; 29(6):355-74. PubMed ID: 1912084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automation in coagulation testing. Clinical applications.
    Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):341-5. PubMed ID: 6606852
    [No Abstract]   [Full Text] [Related]  

  • 16. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different prothrombin complex concentrates--in vitro and in vivo studies.
    Köhler M; Heiden M; Harbauer G; Miyashita C; Mörsdorf S; Braun B; Ernert P; Wenzel E; Rose S; Pindur G
    Thromb Res; 1990 Oct; 60(1):63-70. PubMed ID: 2148989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antithrombin III assays using biological and chromogenic substrates.
    Philo RD; Gaffney PJ
    Br J Haematol; 1982 Jan; 50(1):147-56. PubMed ID: 7055531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogenic substrates for activated partial thromboplastin time testing: are they worth using?
    Tripodi A
    Ric Clin Lab; 1989; 19(4):355-8. PubMed ID: 2517351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation and diagnostic efficacy of synthetic-substrate methods for coagulation and fibrinolytic factors].
    Asai K; Asai M
    Rinsho Byori; 1987 Feb; 35(2):147-59. PubMed ID: 3295327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.